Sign Up to like & get
recommendations!
0
Published in 2021 at "European Thyroid Journal"
DOI: 10.1159/000514182
Abstract: Introduction: Tyrosine kinase inhibitors represent a better treatment in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC). Lenvatinib is usually well-tolerated, but sometimes, it is associated with serious and even life-threatening side effects. The aim…
read more here.
Keywords:
organ perforation;
patients treated;
perforation;
thyroid cancer ... See more keywords